Table 1. TCR usage of IE-1 variant specific T cell populations.

Specificity	Donor	TRAV	CDR3	TRAJ	TRBV	CDR3	TRBJ	TRBD	TRBV Freq.
ELR_MYM/ELK_IYM	H1	19*01	CALGANFGNEKLTF	48*01	27*01	CASSQGLAGLEETQYF	2-5*01	2*01	35/35
	H7	No Data			27*01	CASSQGLAGLQETQYF	2-5*01	2*01	9/9
	H9	No Data			27*01	CASSLGLAGLTDTQYF	2-5*03	2*01	10/10
ELK_IYM	H2	38-2	CAFGGSQGNLIF	42*01	2	CASSFGLSSYNSPLHF	1-6*02	2*01	15/21
		38-2	CAFGGSQGNLIF	42*01	12-3	CASGLTHVPQHF	1-5*01	2*01	1/21
		38-2	CAYRSGNFNKFYF	21*01	6-4	CASSSRDTLGEYTEAFF	1-1*01	1*01	2/21
		21	CAVYNNNDMRF	43*01	6-4	CASSSRDTLGEYTEAFF	1-1*01	1*01	1/21
		13-2	CAVPPGASGTYKYIF	40*01	29-01	CSVEGGTIYEQYF	2-7*01	2*01	1/21
		No Data			19*01	CASRGGPQETQYF	2-5*01	1*01	1/21
	H5	27*01	CAGAEGAAGNKLTF	17*01	7	CASSSPGLAGAQEYF	2-7*-01	2*01	24/30
		24*01	CAFIGYSGYALNF	31	30	CAWRETDNYGYTF	1-2*01	1*01	3/30
		12-2	CAVNRYGNKLVF	47*02	20-1	CSARDENQGAEAFF	1-1*01	1*01	1/30
		1-2*01	CAVYSSGGANNLFF	36*01	10-3	CAIRTGQANEQYF	2-7*01	1*01	1/30
		19*01	CAPNARLMF	31*01	5-6	CASTLGGYAGNTIYF	1-3*01	2*01	1/30
ELR_MYM	H10	20*01	CAVQGTGGFKTIF	9*01	7	CASSLDVGQYLGNEQFF	2-1*01	1*01	8/12
		19*01	CAPNARLMF	31*01	5-6	CASTLGGYAGNTIYF	1-3*01	2*01	2/12
		8-1*01	CAVLGAGNMLTF	39*01	19	CASSMAAPFPFDGYTF	1-2*01	2*01	1/12
		13-2	CAEVAEKSSGDKLTF	46*01	27*01	CASSSYRVSLNTEAFF	1-1*01	1*01	1/12
	H5	38-1	CAFRGAGNMLTF	39*01	2	CASIPWQGANGEQYF	2-7*01	2*01	14/24
		19*01	CAQGSNFGNEKLTF	48*01	27*01	CASSSYRTNLNTEAFF	1-1*01	1*01	9/24
		5*01	CAETQPGAGSYQLTF	28*01	27*01	CASSLGPGQEQYF	2-7*01	1*01	1/24
ELN_IYM	H8	12-3	CAGAEGAAGNKLTF	50*01	20-1	CSAKSRDRTGANVLTF	2-6*01	1*02	5/11
		14	CAETQPGAGSYQLTF	28*01	29-1	CSVVGGQSYEQYF	2-7*01	2*01	5/11
		25*01	CAIYGGSQGNLIF	42*01	20-1	CSANEGIHYGYTF	1-2*01	2*02	1/11